Hosted on MSN
Target’s bad year continues: Sales decline and stock slips as high-stakes holiday shopping season arrives
Today, retail giant Target Corporation (NYSE: TGT) reported its third-quarter fiscal 2025 earnings. Unfortunately, for the company and its investors, the results were a continuation of what Target has ...
The company is banking on its Wegovy pill and next-generation weight loss injectable CagriSema to recapture share of the key U.S. market.
VW’s passenger car sales in the United States were disappointing last year, and most of its SUVs saw declining sales, too. Volkswagen’s US sales fell 13% in 2025, with nearly all models declining.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results